Buchumschlag

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Haanen, John B. A. G. (VerfasserIn) , Obeid, M. (VerfasserIn) , Spain, L. (VerfasserIn) , Carbonnel, F. (VerfasserIn) , Wang, Y. (VerfasserIn) , Robert, C. (VerfasserIn) , Lyon, A. R. (VerfasserIn) , Wick, Wolfgang (VerfasserIn) , Kostine, M. (VerfasserIn) , Peters, S. (VerfasserIn) , Jordan, Karin (VerfasserIn) , Larkin, J. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 October 2022
In: Annals of oncology
Year: 2022, Jahrgang: 33, Heft: 12, Pages: 1217-1238
ISSN:1569-8041
DOI:10.1016/j.annonc.2022.10.001
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2022.10.001
Verlag, lizenzpflichtig, Volltext: https://www.webofscience.com/api/gateway?GWVersion=2&SrcAuth=DOISource&SrcApp=WOS&KeyAID=10.1016%2Fj.annonc.2022.10.001&DestApp=DOI&SrcAppSID=EUW1ED0A3CkKPTUKdji5VIGJ91SpW&SrcJTitle=ANNALS+OF+ONCOLOGY&DestDOIRegistrantName=Elsevier
Volltext
Verfasserangaben:J. Haanen, M. Obeid, L. Spain, F. Carbonnel, Y. Wang, C. Robert, A.R. Lyon, W. Wick, M. Kostine, S. Peters, K. Jordan, J. Larkin on behalf of the EMSO Guidelines Committee

MARC

LEADER 00000caa a2200000 c 4500
001 1879022338
003 DE-627
005 20240307080230.0
007 cr uuu---uuuuu
008 240125s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.annonc.2022.10.001  |2 doi 
035 |a (DE-627)1879022338 
035 |a (DE-599)KXP1879022338 
035 |a (OCoLC)1425215670 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Haanen, John B. A. G.  |e VerfasserIn  |0 (DE-588)1165539497  |0 (DE-627)1029477027  |0 (DE-576)510418872  |4 aut 
245 1 0 |a Management of toxicities from immunotherapy  |b ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up  |c J. Haanen, M. Obeid, L. Spain, F. Carbonnel, Y. Wang, C. Robert, A.R. Lyon, W. Wick, M. Kostine, S. Peters, K. Jordan, J. Larkin on behalf of the EMSO Guidelines Committee 
264 1 |c 18 October 2022 
300 |b Illustrationen, Diagramme 
300 |a 22 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.01.2024 
650 4 |a ADVERSE EVENTS 
650 4 |a ANTI-CTLA-4 
650 4 |a CELL LUNG-CANCER 
650 4 |a ENTERIC NEUROPATHY 
650 4 |a ESMO Clinical Practice Guideline 
650 4 |a IMMUNE CHECKPOINT INHIBITORS 
650 4 |a immunotherapy 
650 4 |a IPILIMUMAB 
650 4 |a MELANOMA 
650 4 |a PD-L1 INHIBITORS 
650 4 |a PNEUMONITIS 
650 4 |a side-effects 
650 4 |a THERAPY 
650 4 |a toxicity 
650 4 |a treatment 
700 1 |a Obeid, M.  |e VerfasserIn  |4 aut 
700 1 |a Spain, L.  |e VerfasserIn  |4 aut 
700 1 |a Carbonnel, F.  |e VerfasserIn  |4 aut 
700 1 |a Wang, Y.  |e VerfasserIn  |4 aut 
700 1 |a Robert, C.  |e VerfasserIn  |4 aut 
700 1 |a Lyon, A. R.  |e VerfasserIn  |4 aut 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
700 1 |a Kostine, M.  |e VerfasserIn  |4 aut 
700 1 |a Peters, S.  |e VerfasserIn  |4 aut 
700 1 |a Jordan, Karin  |d 1974-  |e VerfasserIn  |0 (DE-588)123243327  |0 (DE-627)706224078  |0 (DE-576)293619174  |4 aut 
700 1 |a Larkin, J.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 33(2022), 12, Seite 1217-1238  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a Management of toxicities from immunotherapy ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 
773 1 8 |g volume:33  |g year:2022  |g number:12  |g pages:1217-1238  |g extent:22  |a Management of toxicities from immunotherapy ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 
787 0 8 |i Überarbeitung von  |a Haanen, John B. A. G.  |t Management of toxicities from immunotherapy  |d 2017  |w (DE-627)1580417272  |w (DE-576)510417272 
856 4 0 |u https://doi.org/10.1016/j.annonc.2022.10.001  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.webofscience.com/api/gateway?GWVersion=2&SrcAuth=DOISource&SrcApp=WOS&KeyAID=10.1016%2Fj.annonc.2022.10.001&DestApp=DOI&SrcAppSID=EUW1ED0A3CkKPTUKdji5VIGJ91SpW&SrcJTitle=ANNALS+OF+ONCOLOGY&DestDOIRegistrantName=Elsevier  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240125 
993 |a Article 
994 |a 2022 
998 |g 123243327  |a Jordan, Karin  |m 123243327:Jordan, Karin  |d 50000  |e 50000PJ123243327  |k 0/50000/  |p 11 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 8 
999 |a KXP-PPN1879022338  |e 4467851054 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Management of toxicities from immunotherapy ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of oncology","pubHistory":["1.1990 -"],"recId":"320428796","note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"origin":[{"publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990","dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford"}],"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"id":{"eki":["320428796"],"issn":["1569-8041"],"zdb":["2003498-2"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2022","extent":"22","issue":"12","volume":"33","pages":"1217-1238","text":"33(2022), 12, Seite 1217-1238"}}],"person":[{"display":"Haanen, John B. A. G.","family":"Haanen","given":"John B. A. G.","role":"aut"},{"role":"aut","family":"Obeid","display":"Obeid, M.","given":"M."},{"role":"aut","given":"L.","family":"Spain","display":"Spain, L."},{"role":"aut","given":"F.","family":"Carbonnel","display":"Carbonnel, F."},{"role":"aut","given":"Y.","family":"Wang","display":"Wang, Y."},{"display":"Robert, C.","family":"Robert","given":"C.","role":"aut"},{"given":"A. R.","display":"Lyon, A. R.","family":"Lyon","role":"aut"},{"given":"Wolfgang","family":"Wick","display":"Wick, Wolfgang","role":"aut"},{"display":"Kostine, M.","family":"Kostine","given":"M.","role":"aut"},{"role":"aut","display":"Peters, S.","family":"Peters","given":"S."},{"role":"aut","display":"Jordan, Karin","family":"Jordan","given":"Karin"},{"role":"aut","given":"J.","display":"Larkin, J.","family":"Larkin"}],"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"22 S."}],"title":[{"title":"Management of toxicities from immunotherapy","subtitle":"ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","title_sort":"Management of toxicities from immunotherapy"}],"origin":[{"dateIssuedDisp":"18 October 2022","dateIssuedKey":"2022"}],"language":["eng"],"id":{"eki":["1879022338"],"doi":["10.1016/j.annonc.2022.10.001"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1879022338","note":["Gesehen am 25.01.2024"],"name":{"displayForm":["J. Haanen, M. Obeid, L. Spain, F. Carbonnel, Y. Wang, C. Robert, A.R. Lyon, W. Wick, M. Kostine, S. Peters, K. Jordan, J. Larkin on behalf of the EMSO Guidelines Committee"]}} 
SRT |a HAANENJOHNMANAGEMENT1820 

Ähnliche Einträge